Drug Shortage Report for SERC
Report ID | 128455 |
Drug Identification Number | 02243878 |
Brand name | SERC |
Common or Proper name | BETAHISTINE HYDROCHLORIDE |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | BETAHISTINE HYDROCHLORIDE |
Strength(s) | 16MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 4x25 |
ATC code | N07CA |
ATC description | ANTIVERTIGO PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-12-03 |
Actual start date | 2020-12-07 |
Estimated end date | 2021-02-02 |
Actual end date | 2021-02-02 |
Shortage status | Resolved |
Updated date | 2021-02-03 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2021-02-03 | French | Compare |
v13 | 2021-02-03 | English | Compare |
v12 | 2021-01-20 | French | Compare |
v11 | 2021-01-20 | English | Compare |
v10 | 2021-01-05 | French | Compare |
v9 | 2021-01-05 | English | Compare |
v8 | 2020-12-22 | French | Compare |
v7 | 2020-12-22 | English | Compare |
v6 | 2020-12-08 | French | Compare |
v5 | 2020-12-08 | English | Compare |
v4 | 2020-12-04 | English | Compare |
v3 | 2020-11-17 | French | Compare |
v2 | 2020-11-17 | English | Compare |
v1 | 2020-11-17 | English | Compare |
Showing 1 to 14 of 14